Next Generation Labs Granted European Patent for TFN ® Synthetic...

Patent grant by the European Patent Office is a significant milestone for Next Generation Labs, as it solidifies our TFN® synthetic nicotine IP portfolio across the majority of European countries(PRWeb June 28, 2021)Read the full story at https://www.prweb.com/releases/next_generation_labs_granted_european_patent_for_tfn_synthetic_nicotine_manufacturing_process_further_strengthening_ip_enforcement_efforts_against_tfn_violators/prweb18033390.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news